An Equation to Estimate the Concentration of Serum Apolipoprotein B

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Hwang, You Cheol ^a   Ahn, Hong Yup ^b   Lee, Woo Je ^c   Park, Cheol Young ^d   Park, Sung Woo ^d  

^a Kyung Hee University Hospital   (South Korea)

^b Dongguk University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; EXTERNAL VALIDITY; FEMALE; HUMAN; INTERNAL VALIDITY; LINEAR REGRESSION ANALYSIS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NUTRITION SURVEYS; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84871347947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051607     Document Type: Article

References (15)

1. Marcovina S, Packard CJ, (2006) Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 259: 437-446.
2. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, et al. (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358: 2026-2033.
3. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, et al. (2008) Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372: 224-233.
4. Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, et al. (2006) Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 259: 247-258.
5. Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, et al. (2000) Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex-CAPS). Circulation 101: 477-484.
6. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, et al. (2008) Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 117: 3002-3009.
7. Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, et al. (1999) Thrombogenic factors and recurrent coronary events. Circulation 99: 2517-2522.
8. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
9. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 33 Suppl 1: S62-69.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
11. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, et al. (2008) Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31: 811-822.
12. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003.
13. European Association for Cardiovascular Prevention & Rehabilitation (2011) Reiner Z, Catapano AL, De Backer G, Graham I, et al. (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32: 1769-1818.
14. Sniderman AD, Blank D, Zakarian R, Bergeron J, Frohlich J, (2003) Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin Biochem 36: 499-504.
15. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ, (1990) Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 36: 36-42.